Berta Laquente

874 total citations
29 papers, 542 citations indexed

About

Berta Laquente is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Berta Laquente has authored 29 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Berta Laquente's work include Pancreatic and Hepatic Oncology Research (21 papers), Gallbladder and Bile Duct Disorders (5 papers) and Renal cell carcinoma treatment (4 papers). Berta Laquente is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Gallbladder and Bile Duct Disorders (5 papers) and Renal cell carcinoma treatment (4 papers). Berta Laquente collaborates with scholars based in Spain, United States and Palestinian Territory. Berta Laquente's co-authors include Francesc Viñals, Josep R. Germà, Gabriel Capellá, M. Morell, Oriol Casanovas, Teresa Serrano, Teresa Macarulla, Joan Maurel, Maica Galán and Mariona Graupera and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Berta Laquente

26 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berta Laquente Spain 13 357 175 166 161 105 29 542
Hirotsugu Notsuda Japan 13 223 0.6× 144 0.8× 122 0.7× 196 1.2× 92 0.9× 49 537
Erin K. Crane United States 13 195 0.5× 126 0.7× 109 0.7× 75 0.5× 76 0.7× 38 535
Amir Khan Pakistan 13 190 0.5× 123 0.7× 115 0.7× 118 0.7× 144 1.4× 33 530
Sameer Gupta India 14 225 0.6× 194 1.1× 155 0.9× 119 0.7× 193 1.8× 68 572
Ahmed Elattar United Kingdom 14 465 1.3× 408 2.3× 302 1.8× 108 0.7× 92 0.9× 32 1.1k
Jia Song China 12 387 1.1× 133 0.8× 113 0.7× 220 1.4× 68 0.6× 27 631
Carla M. van Herpen Netherlands 14 325 0.9× 98 0.6× 195 1.2× 146 0.9× 52 0.5× 27 608
C. Stoffregen Germany 15 264 0.7× 181 1.0× 201 1.2× 246 1.5× 135 1.3× 41 678
Daniel Pinďák Slovakia 12 285 0.8× 88 0.5× 174 1.0× 86 0.5× 163 1.6× 47 476
Masaaki Nishitani Japan 15 220 0.6× 170 1.0× 227 1.4× 111 0.7× 230 2.2× 35 568

Countries citing papers authored by Berta Laquente

Since Specialization
Citations

This map shows the geographic impact of Berta Laquente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Laquente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Laquente more than expected).

Fields of papers citing papers by Berta Laquente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Laquente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Laquente. The network helps show where Berta Laquente may publish in the future.

Co-authorship network of co-authors of Berta Laquente

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Laquente. A scholar is included among the top collaborators of Berta Laquente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Laquente. Berta Laquente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fort, Esther, María Ortiz, Anna Feliu, et al.. (2024). Metagenomic Study Reveals Phage–Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic Diseases. International Journal of Molecular Sciences. 25(20). 10988–10988. 1 indexed citations
3.
García‐Carbonero, Rocio, Roberto Pazo-Cid, Teresa Macarulla, et al.. (2024). VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS4210–TPS4210. 1 indexed citations
4.
Macarulla, Teresa, Florian Castet, Rocio García‐Carbonero, et al.. (2023). 1686TiP Olaparib and durvalumab (MEDI4736) phase II study in patients with metastatic pancreatic cancer and DNA damage repair genes alterations. Annals of Oncology. 34. S923–S923. 2 indexed citations
5.
6.
7.
Loras, Carme, Carlos Guarner‐Argente, Xavier Andújar, et al.. (2021). Is a coaxial plastic stent within a lumen-apposing metal stent useful for the management of distal malignant biliary obstruction?. Surgical Endoscopy. 35(8). 4873–4881. 30 indexed citations
8.
Laquente, Berta, Teresa Macarulla, Cristina Bugés, et al.. (2020). Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice. BMC Palliative Care. 19(1). 103–103. 11 indexed citations
9.
Busquets, Juli, Berta Laquente, Mariona Calvo, et al.. (2019). Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study. Revista Española de Enfermedades Digestivas. 111(9). 683–689. 4 indexed citations
10.
Macarulla, Teresa, Alfredo Carrato, Rienzi Díaz‐Navarro, et al.. (2018). Management and supportive treatment of frail patients with metastatic pancreatic cancer. Journal of Geriatric Oncology. 10(3). 398–404. 6 indexed citations
11.
Laquente, Berta, José A. López-Martín, Donald Richards, et al.. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC Cancer. 17(1). 137–137. 53 indexed citations
12.
Busquets, Juli, Juan Fabregat, Helena Verdaguer, et al.. (2017). Experiencia inicial en el tratamiento del adenocarcinoma de páncreas borderline resectable. Cirugía Española. 95(8). 447–456. 3 indexed citations
13.
Taı̈eb, Julien, Jean‐Luc Van Laethem, Berta Laquente, et al.. (2017). What treatment in 2017 for inoperable pancreatic cancers?. Annals of Oncology. 28(7). 1473–1483. 25 indexed citations
14.
Busquets, Juli, Juan Fabregat, Helena Verdaguer, et al.. (2017). Initial Experience in the Treatment of “Borderline Resectable” Pancreatic Adenocarcinoma. Cirugía Española (English Edition). 95(8). 447–456. 3 indexed citations
15.
Vera, Ruth, E. Dotor, Jaime Feliú, et al.. (2016). SEOM Clinical Guideline for the treatment of pancreatic cancer (2016). Clinical & Translational Oncology. 18(12). 1172–1178. 24 indexed citations
16.
Salazar, Ramón, Jaume Capdevila, Berta Laquente, et al.. (2015). A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer. 15(1). 60–60. 31 indexed citations
17.
Benavides, Manuel, A. Antón, Javier Gállego, et al.. (2015). Biliary tract cancers: SEOM clinical guidelines. Clinical & Translational Oncology. 17(12). 982–987. 53 indexed citations
18.
Fabregat, Juan, Juli Busquets, Núria Peláez, et al.. (2010). Surgical treatment of pancreatic adenocarcinoma using cephalic duodenopancreatectomy (Part 2). Long term follow up after 204 cases. Cirugía Española (English Edition). 88(6). 374–382. 1 indexed citations
19.
Laquente, Berta, Francesc Viñals, & Josep R. Germà. (2007). Metronomic chemotherapy: an antiangiogenic scheduling. Clinical & Translational Oncology. 9(2). 93–98. 52 indexed citations
20.
Majem, Margarita, Maica Galán, Montserrat Muñoz-Mateu, et al.. (2007). The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity. Clinical & Translational Oncology. 9(12). 784–788. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hirotsugu Notsuda Breakdown of academic impact, for papers by Erin K. Crane Breakdown of academic impact, for papers by Amir Khan Breakdown of academic impact, for papers by Sameer Gupta Breakdown of academic impact, for papers by Ahmed Elattar Breakdown of academic impact, for papers by Jia Song Breakdown of academic impact, for papers by Carla M. van Herpen Breakdown of academic impact, for papers by C. Stoffregen Breakdown of academic impact, for papers by Daniel Pinďák Breakdown of academic impact, for papers by Masaaki Nishitani
Rankless by CCL
2026